Alembic Pharmaceuticals Ltd
Ticker: APLLTD
Decent
68/100
☆ Add to Watchlist
Investing Reference
Price
917.65
Market Cap
18037.62
Debt/Equity
0.2423
ROE %
11.659
PB
3.4758
Promoter %
69.675
Pledge %
0.000
1Y Rev Growth %
7.535
5Y Rev Growth %
7.852
NP Margin %
8.671
NP Margin 5Y Avg %
11.039
Trading Reference
1M Return %
-4.099
6M Return %
8.412
1Y Return %
-20.194
% Away 52W High
30.954
% Away 52W Low
26.538
Daily Volume
32949
Investment Verdict
Hold
Score 65/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 23/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Alembic Pharmaceuticals Ltd is currently trading near a strong support level, with the 50-day EMA showing bullish momentum. If it breaks above the resistance level, there is a potential for upside. However, if it fails to hold the support, a downside risk is present.
Upside Probability: 15% | Downside Probability: 10%
Probability estimates are technical-context statements, not investment advice.
More Options
Z
Zensar Technologies Ltd
Zensar Technologies has potential but faces challenges in growth consistency and valuation. Caution is advised.
View details
I
IIFL Finance Ltd
IIFL Finance Ltd shows decent potential with some growth prospects, but faces challenges in profitability and valuation metrics.
View details
B
BEML Ltd
BEML Ltd shows potential in a growing sector, but faces challenges in profitability and execution risks.
View details
A
Anant Raj Ltd
Anant Raj Ltd shows potential in a growing sector but faces significant risks and challenges that may hinder performance.
View details
S
Sai Life Sciences Ltd
Sai Life Sciences Ltd shows potential for growth in a future-ready sector, but faces challenges in profitability consistency and valuation metrics.
View details
G
Grindwell Norton Ltd
Grindwell Norton Ltd shows a decent investment potential with consistent growth and profitability metrics, though some execution risks exist.
View details
G
Gujarat Mineral Development Corporation Ltd
The stock shows decent fundamentals but lacks strong growth drivers and competitive advantages.
View details
C
Century Plyboards (India) Ltd
Century Plyboards shows potential for growth but faces challenges in profitability and valuation metrics. Investors should be cautious and monitor market conditions closely.
View details
C
Capri Global Capital Ltd
Capri Global Capital Ltd shows potential but faces significant risks that may affect its growth and stability.
View details
J
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd shows potential for growth but faces challenges in profitability and valuation. Investors should be cautious.
View details
A
Aditya Birla Lifestyle Brands Ltd
Aditya Birla Lifestyle Brands Ltd shows potential for growth but faces challenges in profitability and valuation metrics. Investors should be cautious and consider market conditions.
View details
G
Gabriel India Ltd
Gabriel India Ltd shows potential in a transitioning sector, but faces challenges in growth consistency and profitability metrics.
View details
D
Deepak Fertilisers and Petrochemicals Corp Ltd
The company shows potential for growth but faces several challenges that could impact its performance.
View details
V
Vinati Organics Ltd
Vinati Organics Ltd shows potential for growth with solid fundamentals, but investors should be cautious of execution risks and market volatility.
View details
V
Vedant Fashions Ltd
Vedant Fashions Ltd shows potential for growth in a favorable sector, but faces challenges in profitability and valuation metrics.
View details
V
Ventive Hospitality Ltd
Ventive Hospitality Ltd shows potential but faces significant challenges in profitability and market conditions, making it a risky investment.
View details
Business Overview
Alembic Pharmaceuticals Ltd is a leading Indian pharmaceutical company focused on developing, manufacturing, and marketing a wide range of generic and branded formulations. With a strong commitment to quality and innovation, Alembic serves healthcare providers and patients both domestically and internationally. The company plays a crucial role in enhancing access to affordable medicines, contributing to public health. Alembic's robust pipeline and state-of-the-art facilities underscore its dedication to delivering effective healthcare solutions.
- Established player in the Indian pharma sector
- Focus on generics and branded formulations
- Strong commitment to quality and innovation
- Expanding international presence
- Robust R&D pipeline for sustainable growth
Investment Thesis
Alembic Pharmaceuticals Ltd stands out due to its strong promoter credibility, robust growth in digital services, and attractive valuation compared to peers. These factors position the company for sustained growth and profitability, making it a compelling investment opportunity.
- Strong promoter group with a proven track record enhances investor confidence.
- Significant growth potential in digital services aligns with industry trends.
- Valuation metrics indicate Alembic is attractively priced relative to competitors.
- Diversified product portfolio mitigates risks and supports revenue stability.
- Commitment to R&D ensures innovation and long-term competitive advantage.
Opportunity vs Risk
Opportunities
- Growing demand for generic drugs
- Strong pipeline of new products
- Expanding international markets
- Strategic partnerships with global firms
Risks ⚠️
- Regulatory changes affecting approvals
- Intense competition in generics
- Currency fluctuations impacting profits
- R&D costs may escalate
Peer Perspective
Alembic Pharmaceuticals Ltd trades at a discount to peers like Sun Pharma and Dr. Reddy's, reflecting concerns over margin stability; a consistent improvement in operational efficiency could trigger a rerating.
Future Outlook
Alembic Pharmaceuticals Ltd is well-positioned for growth, driven by its robust pipeline and expanding market presence. Successful execution and effective cost control will be key to realizing its full potential in the coming years.
AI FAQs for Retail Users
- Q: What does Alembic Pharmaceuticals do?A: Alembic Pharmaceuticals is involved in manufacturing and marketing generic and branded pharmaceuticals.
- Q: Is Alembic Pharmaceuticals a good investment?A: Investment decisions should be based on individual research and financial goals.
- Q: What are the main products of Alembic Pharmaceuticals?A: The company produces a range of formulations including tablets, capsules, and injectables.
- Q: How has Alembic Pharmaceuticals performed recently?A: Recent performance can be checked through financial news and stock market reports.
- Q: What are the risks of investing in Alembic Pharmaceuticals?A: Risks include market volatility, regulatory changes, and competition in the pharmaceutical sector.
📊 Stock Investment Checklist (100 Points)
Alembic Pharmaceuticals Ltd • Updated: 2025-09-17 01:10:03
-
10BusinessHighPharmaceutical sector is essential and growing, but competition is intense.
-
10GrowthHighConsistent revenue growth, but profit margins are under pressure.
-
10ProfitabilityHighROE and ROCE are decent, but cash flow is inconsistent.
-
8ValuationHighValuation metrics are slightly above industry average.
-
7BalanceHighModerate debt levels, but liquidity is satisfactory.
-
6GovernanceGoodPromoter holding is strong, but some pledging exists.
-
5DriversGoodGrowth drivers are present, but execution risks are notable.
-
5TechnicalsGoodMarket sentiment is neutral with low liquidity.
Final Score & Verdict
Score 68 / 100
• Decent
Alembic Pharmaceuticals shows potential for growth but faces challenges in profitability and market competition.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100